Army-developed Zika vaccine induces strong immune response in three phase 1 studies

(Walter Reed Army Institute of Research) Three Phase 1 human clinical trials evaluating an Army-developed Zika purified inactivated virus (ZPIV) vaccine have shown it was safe and well-tolerated in healthy adults and induced a robust immune response. Initial findings from the trials were published today in The Lancet.
Source: EurekAlert! - Biology - Category: Biology Source Type: news